In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Modulation of the Inflammatory Response: A Potential Novel Use for Vagus Nerve Stimulation

    Final Number:
    110

    Authors:
    Sudhakar Vadivelu DO; Megan McCarty BS; Sangeeta Chavan; Sara Stream; Kevin J. Tracey; Ashesh Mehta MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: The neural modulation of the immune response is thought to be mediated, in part, through the vagus nerve. Prior studies in experimental animals have shown vagus nerve stimulation to modulate cytokines response to inducers of inflammation. Tumor necrosis factor (TNF) is a cytokine that is known to play an important role in the pathophysiology of sepsis and other inflammatory disorders. The production of TNF in response to endotoxin challenge can be used as an index of the magnitude of the inflammatory response. We studied 7 patients who underwent vagus nerve stimulation for epilepsy to investigate for changes in TNF induction and this response over time.

    Methods: We conducted a prospective clinical study recruiting patients with intractable epilepsy who underwent vagus nerve stimulator implantation. Peripheral whole blood was drawn on the day of surgery at four time points peri-operatively (timed before and after intraoperative stimulation): 1. prior to anesthesia, 2. after anesthetic induction and anterior cervical dissection, 3. after vagal nerve stimulation in situ, and 4. four hours after vagal nerve stimulation. On each follow - up clinical visit a before and after vagus nerve stimulation blood draw was obtained. Whole blood samples were stimulated with endotoxin lipopolysaccharide concentrations 0.1, 1, and 10ng/mL-1 ex vivo. TNF responses were recorded.

    Results: Seven epileptic patients consented to the study (male = 4, female = 3). Four patients (4/7 [57%]) demonstrated TNF response suppression after direct vagus nerve stimulation intraoperatively. We found 4/5 [80%] patients (2 patients without followup) with serial followup visits to sustain chronic suppression of inflammatory responses. No patients experienced intraoperative complications or developed adverse events from serial phlebotomy.

    Conclusions: Results here support the theory of a direct link between the brain and systemic inflammation via the vagus nerve in humans. This paves the way for the use of vagus nerve stimulation as treatment for inflammatory disorders.

    Patient Care: May present a novel modality to treat inflammatory disorders.

    Learning Objectives: 1. Pathophysiology of neuromodulation of systemic inflammation 2. VNS activity and effects on TNF 3. Novel use of VNS for inflammatory disorders

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy